Clinical validation remains limited because large-scale human trials and regulatory approval are not established
But if you have diabetes, you may have heard you should stay away from it completely
Abstract Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity
Typically, roughly 25-40% of weight lost through caloric restriction comes from lean tissue rather than fat
Trends Cardiovasc Med 33(3):159166 Lepsen EW, Lundgren JR, Hartmann B et al (2015) GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women
In interviews with People and others, Serena Williams added that she did lots of research first and consulted a doctor through Ro, the telehealth company she serves as an ambassador for